Large Insider Purchases
Institutional-Scale SEC Form 4 Buy Signals
The Signal of $1M+ Conviction
When a corporate executive invests more than $1,000,000 of their own capital into company shares, it represents the highest level of conviction. These seven-figure purchases reflect management's belief in the company's future value.
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2018-04-25 23:16 | 2018-04-23 | APPN | Appian Corporation | Abdiel Capital Management, LLC | 10% owner | Services-Prepackaged Software | BUY | $26.23 | 39,200 | $1,028,216 | 5,561,248 | +0.7% |
| 2018-04-25 23:12 | 2018-04-23 | IVAC | N/A | First Eagle Investment Management, LLC | 10% owner | Other | BUY | $6.14 | 222,000 | $1,362,503 | 4,684,055 | +5.0% |
| 2018-04-25 00:18 | 2018-04-20 | CATM | N/A | Hudson Executive Capital LP | 10% owner | Other | BUY | $25.39 | 350,500 | $8,899,195 | 7,696,685 | +4.8% |
| 2018-04-25 01:07 | 2018-04-23 | N/A | N/A | AXA Equitable Holdings, Inc. | 10% owner | Other | BUY | $26.54 | 8,160,000 | $216,566,400 | 128,187,163 | +6.8% |
| 2018-04-23 23:18 | 2018-04-23 | SURF | N/A | GRAYZEL DAVID S. | Director | Other | BUY | $15.00 | 100,000 | $1,500,000 | 4,645,453 | +2.2% |
| 2018-04-23 23:18 | 2018-04-23 | SURF | N/A | Atlas Venture Fund IX, L.P. | 10% owner | Other | BUY | $15.00 | 100,000 | $1,500,000 | 4,645,453 | +2.2% |
| 2018-04-23 23:16 | 2018-04-23 | SURF | N/A | Shanafelt Armen | Director, 10% owner | Other | BUY | $15.00 | 266,000 | $3,990,000 | 3,447,817 | +8.4% |
| 2018-04-23 23:46 | 2018-04-23 | SURF | N/A | Florence Anthony A. Jr. | 10% owner | Other | BUY | $15.00 | 133,333 | $1,999,995 | 3,312,877 | +4.2% |
| 2018-04-23 23:48 | 2018-04-23 | SURF | N/A | Sonsini Peter W. | 10% owner | Other | BUY | $15.00 | 133,333 | $1,999,995 | 3,312,877 | +4.2% |
| 2018-04-23 23:16 | 2018-04-23 | SURF | N/A | LV Management Group, LLC | 10% owner | Other | BUY | $15.00 | 266,000 | $3,990,000 | 3,447,817 | +8.4% |
| 2018-04-23 23:45 | 2018-04-23 | SURF | N/A | New Enterprise Associates 14, L.P. | 10% owner | Other | BUY | $15.00 | 133,333 | $1,999,995 | 3,312,877 | +4.2% |
| 2018-04-23 23:48 | 2018-04-23 | SURF | N/A | Viswanathan Ravi | 10% owner | Other | BUY | $15.00 | 133,333 | $1,999,995 | 3,312,877 | +4.2% |
| 2018-04-24 00:02 | 2018-04-19 | AFSI | N/A | Zyskind Barry D | Director, Officer, 10% owner - Chairman, President and CEO | Other | BUY | $12.62 | 2,945,113 | $37,152,600 | 2,945,113 | +100.0% |
| 2018-04-23 23:46 | 2018-04-23 | SURF | N/A | BASKETT FOREST | 10% owner | Other | BUY | $15.00 | 133,333 | $1,999,995 | 3,312,877 | +4.2% |
| 2018-04-23 20:28 | 2018-04-19 | RDUS | N/A | BIOTECH GROWTH N V | 10% owner | Other | BUY | $33.80 | 40,000 | $1,351,936 | 6,050,913 | +0.7% |
| 2018-04-23 23:47 | 2018-04-23 | SURF | N/A | SANDELL SCOTT D | 10% owner | Other | BUY | $15.00 | 133,333 | $1,999,995 | 3,312,877 | +4.2% |
| 2018-04-23 23:47 | 2018-04-23 | SURF | N/A | KERINS PATRICK J | 10% owner | Other | BUY | $15.00 | 133,333 | $1,999,995 | 3,312,877 | +4.2% |
| 2018-04-23 23:47 | 2018-04-23 | SURF | N/A | MOTT DAVID M | 10% owner | Other | BUY | $15.00 | 133,333 | $1,999,995 | 3,312,877 | +4.2% |
| 2018-04-23 23:45 | 2018-04-23 | SURF | N/A | BARRETT M JAMES | 10% owner | Other | BUY | $15.00 | 133,333 | $1,999,995 | 3,312,877 | +4.2% |
| 2018-04-23 23:43 | 2018-04-23 | SURF | N/A | Novartis Institutes for BioMedical Research, Inc. | 10% owner | Other | BUY | $15.00 | 766,666 | $11,499,990 | 3,948,482 | +24.1% |
| 2018-04-24 01:50 | 2018-04-19 | AKAO | N/A | DUGGAN ROBERT W | 10% owner | Other | BUY | $13.06 | 468,337 | $6,118,636 | 6,950,906 | +7.2% |
| 2018-04-23 23:45 | 2018-04-23 | SURF | N/A | BARRIS PETER J | 10% owner | Other | BUY | $15.00 | 133,333 | $1,999,995 | 3,312,877 | +4.2% |
| 2018-04-21 00:38 | 2018-04-18 | EYEG | KIORA PHARMACEUTICALS INC | ARMISTICE CAPITAL, LLC | 10% owner | Pharmaceutical Preparations | BUY | $0.49 | 2,534,478 | $1,231,249 | 16,246,978 | +18.5% |
| 2018-04-20 01:48 | 2018-04-17 | AKCA | N/A | IONIS PHARMACEUTICALS INC | 10% owner | Other | BUY | $18.75 | 10,666,666 | $199,999,988 | 64,114,545 | +20.0% |
| 2018-04-19 23:22 | 2018-04-17 | VRML | Aspira Women's Health Inc. | Schuler Henri George | 10% owner | In Vitro & In Vivo Diagnostic Substances | BUY | $1.00 | 2,107,774 | $2,107,774 | 1,007,377 | +100.0% |
| 2018-04-19 23:20 | 2018-04-17 | VRML | Aspira Women's Health Inc. | SCHULER JACK W | 10% owner | In Vitro & In Vivo Diagnostic Substances | BUY | $1.00 | 2,838,090 | $2,838,090 | 13,416,342 | +26.8% |
| 2018-04-19 23:08 | 2018-04-18 | TDF | TEMPLETON DRAGON FUND INC | CITY OF LONDON INVESTMENT GROUP PLC | 10% owner | Other | BUY | $21.88 | 80,300 | $1,756,948 | 3,861,160 | +2.1% |
| 2018-04-18 19:28 | 2018-04-17 | N/A | Bain Capital Specialty Finance, Inc. | Hough Thomas A. | Director | Other | BUY | $20,000.00 | 981 | $19,627,000 | 6,034 | +19.4% |
| 2018-04-18 19:39 | 2018-04-17 | N/A | Bain Capital Specialty Finance, Inc. | BAIN CAPITAL CREDIT MEMBER, LLC | 10% owner | Other | BUY | $55,526,697.00 | 2,724,568 | $151,286,265,123,498 | 16,527,920 | +19.7% |
| 2018-04-18 19:31 | 2018-04-17 | N/A | Bain Capital Specialty Finance, Inc. | MARGOLIS JAY | Director | Other | BUY | $145,000.00 | 7,115 | $1,031,648,900 | 13,459 | +112.1% |
| 2018-04-18 23:28 | 2018-04-18 | APO | Apollo Global Management Inc. | TIGER GLOBAL MANAGEMENT LLC | 10% owner | Investment Advice | BUY | $29.01 | 50,000 | $1,450,500 | 34,372,807 | +0.1% |
| 2018-04-18 01:18 | 2018-04-13 | AVGO | Broadcom Inc. | Silver Lake Group, L.L.C. | Director | Semiconductors & Related Devices | BUY | $247.94 | 344,761 | $85,478,491 | 4,863 | +100.0% |
| 2018-04-18 04:59 | 2018-04-13 | EYEG | KIORA PHARMACEUTICALS INC | ARMISTICE CAPITAL, LLC | 10% owner | Pharmaceutical Preparations | BUY | $0.36 | 10,479,970 | $3,740,301 | 13,712,500 | +324.2% |
| 2018-04-17 23:55 | 2018-04-13 | ANGI | Angi Inc. | Luxor Capital Group, LP | 10% owner | Services-Advertising | BUY | $13.50 | 807,465 | $10,900,778 | 4,321,958 | +23.0% |
| 2018-04-18 00:21 | 2018-04-13 | PDVW | Anterix Inc. | Owl Creek Asset Management, L.P. | 10% owner | Telephone Communications (No Radiotelephone) | BUY | $30.00 | 74,048 | $2,221,788 | 2,467,145 | +3.1% |
| 2018-04-17 23:18 | 2018-04-16 | JPM | JPMORGAN CHASE & CO | HOBSON MELLODY L | Director | National Commercial Banks | BUY | $111.05 | 18,000 | $1,998,814 | 28,000 | +180.0% |
| 2018-04-16 21:24 | 2017-08-29 | AMMA | SCWorx Corp. | Tracy Joel Daniel | Director | Services-Computer Processing & Data Preparation | BUY | $50,000.00 | 45,872 | $2,293,600,000 | 334,860 | +15.9% |
| 2018-04-16 21:24 | 2017-08-29 | AMMA | SCWorx Corp. | Gamberale Joseph | Director | Services-Computer Processing & Data Preparation | BUY | $240,000.00 | 220,183 | $52,843,920,000 | 261,850 | +528.4% |
| 2018-04-16 21:25 | 2017-08-29 | AMMA | SCWorx Corp. | SHEFTS MARK | Director | Services-Computer Processing & Data Preparation | BUY | $200,000.00 | 183,486 | $36,697,200,000 | 222,374 | +471.8% |
| 2018-04-17 00:05 | 2018-04-13 | ANGI | Angi Inc. | Luxor Capital Group, LP | 10% owner | Services-Advertising | BUY | $13.50 | 807,465 | $10,900,778 | 4,530,305 | +21.7% |
| 2018-04-17 00:48 | 2018-04-12 | ETM | N/A | FIELD JOSEPH M | Director, Officer - Chairman Emeritus | Other | BUY | $9.65 | 415,125 | $4,005,084 | 6,302,022 | +7.1% |
| 2018-04-14 02:39 | 2018-04-11 | CATM | N/A | Hudson Executive Capital LP | 10% owner | Other | BUY | $23.55 | 958,355 | $22,569,260 | 7,346,185 | +15.0% |
| 2018-04-13 22:42 | 2018-03-27 | VGZ | VISTA GOLD CORP | SUN VALLEY GOLD MASTER FUND, LTD | 10% owner | Gold and Silver Ores | BUY | $0.76 | 1,374,592 | $1,037,817 | 13,281,529 | +11.5% |
| 2018-04-12 00:52 | 2018-04-09 | ETM | N/A | FIELD JOSEPH M | Director, Officer - Chairman Emeritus | Other | BUY | $9.70 | 375,000 | $3,635,813 | 5,886,897 | +6.8% |
| 2018-04-12 01:01 | 2018-04-09 | INFI | N/A | BVF PARTNERS L P/IL | 10% owner | Other | BUY | $1.97 | 1,510,000 | $2,970,019 | 950,473 | +100.0% |
| 2018-04-11 01:29 | 2018-04-09 | CODX | Co-Diagnostics, Inc. | Satterfield Brent | Director, Officer, 10% owner - Chief Science Officer | Surgical & Medical Instruments & Apparatus | BUY | $4,920.00 | 2,400 | $11,808,000 | 2,272,198 | +0.1% |
| 2018-04-11 00:32 | 2018-04-06 | AVEO | N/A | Viswanathan Ravi | 10% owner | Other | BUY | $2.30 | 920,976 | $2,115,021 | 17,283,670 | +5.6% |
| 2018-04-11 00:31 | 2018-04-06 | AVEO | N/A | Sonsini Peter W. | 10% owner | Other | BUY | $2.30 | 920,976 | $2,115,021 | 17,283,670 | +5.6% |
| 2018-04-11 00:31 | 2018-04-06 | AVEO | N/A | Sakoda Jon | 10% owner | Other | BUY | $2.30 | 920,976 | $2,115,021 | 17,283,670 | +5.6% |
| 2018-04-11 00:29 | 2018-04-06 | AVEO | N/A | Florence Anthony A. Jr. | 10% owner | Other | BUY | $2.30 | 920,976 | $2,115,021 | 17,283,670 | +5.6% |
Institutional Conviction in Form 4
Tracking these institutional-scale purchases allows you to follow the "smart money" when their conviction is highest. When an executive or a 10% beneficial owner commits a seven-figure sum to an open-market transaction, it bypasses the routine noise of stock-based compensation. These trades are often a precursor to major corporate developments or a signal that management views the current market valuation as significantly disconnected from the company’s internal growth trajectory. By monitoring these high-value entries, investors can align their portfolios with the capital of those who possess the most intimate understanding of a business's long-term health and potential.
Filtering the Market Noise
Our platform is designed to eliminate the noise and focus strictly on high-impact accumulation from directors and CEOs betting big on their company’s future. The SEC EDGAR database is frequently flooded with thousands of automated Form 4 filings, many of which involve small, technical, or pre-scheduled trades that offer little predictive value for the average investor. By applying a strict $1,000,000 minimum threshold, we isolate the transactions where insiders are taking substantial personal financial risk. This high-conviction filter serves as a powerful transparency tool, identifying the exact moments when corporate leadership moves away from passive ownership toward aggressive capital deployment.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.